LYMPHOMA, NON-HODGKIN
Clinical trials for LYMPHOMA, NON-HODGKIN explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, NON-HODGKIN trials appear
Sign up with your email to follow new studies for LYMPHOMA, NON-HODGKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets tough blood cancers in early safety trial
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
High-Dose vitamin d tested to boost lymphoma treatment
Disease control Not yet recruitingThis study aims to see if giving a large, upfront dose of vitamin D (ergocalciferol) can raise vitamin D levels to normal faster and more safely than giving smaller weekly doses in people newly diagnosed with aggressive non-Hodgkin lymphoma. All participants will receive standard…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: NA • Sponsor: Phramongkutklao College of Medicine and Hospital • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Music and mindfulness ease the harsh journey of stem cell transplant
Symptom relief Not yet recruitingThis study is testing whether an online program combining mindfulness and music therapy can help patients feel better during and after a stem cell transplant. It aims to improve quality of life, reduce symptoms like pain and fatigue, and lower stress for 165 adults with blood can…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Scientists trace radioactive drug through healthy volunteers
Knowledge-focused Not yet recruitingThis is a very early, first-in-human study to understand how a potential new drug for non-Hodgkin lymphoma is processed by the body. Six healthy adult male volunteers will take a single, small oral dose containing a tiny, safe amount of radioactive tracer. Researchers will closel…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC